GH Secretagogue Comparison: Ipamorelin, CJC-1295, Sermorelin and GHRP-6 for Research (UK 2026)GH secretagogues are among the most widely researched peptide classes — and the most frequently confused. Ipamorelin, CJC-1295, sermorelin, and GHRP-6 all stimulate growth hormone release but through fundamentally different mechanisms, with different receptor targets, different GH pulse profiles, different selectivity, and different…
William
AOD-9604 and Fat Metabolism Research: Lipolysis, Adipogenesis and Metabolic Biology (UK 2026)AOD-9604 (Anti-Obesity Drug 9604) is a modified fragment of the C-terminal region of growth hormone — specifically the 176–191 amino acid fragment of GH, with a tyrosine substitution at the N-terminal position (Tyr-hGH177-191). It was developed by Monash University researchers who identified that…
GHK-Cu and Wound Healing Research: Skin Regeneration, Collagen Remodelling and Dermal Biology (UK 2026)GHK-Cu (Glycine-Histidine-Lysine copper complex) is a naturally occurring copper-binding tripeptide present in human plasma, saliva, and urine — with the highest concentrations found in skin wound fluid during the acute repair phase. Its biology in wound healing is uniquely well-characterised: GHK-Cu…
Ipamorelin and Sleep Quality Research: GH Pulse Timing, Slow-Wave Sleep and Recovery Biology (UK 2026)Ipamorelin is the most selective GH secretagogue receptor (GHS-R1a) agonist available for research — it produces robust GH pulses with minimal co-secretion of cortisol, prolactin, or ACTH that accompany less selective secretagogues like GHRP-6. This selectivity makes it uniquely suited…
CJC-1295 and Growth Hormone Pulse Physiology: DAC Technology and Extended GH Axis Research (UK 2026)
CJC-1295 and Growth Hormone Pulse Physiology: DAC Technology and Extended GH Axis Research (UK 2026)CJC-1295 is a synthetic GHRH analogue distinguished from sermorelin and other short-acting GHRH peptides by its Drug Affinity Complex (DAC) technology — a modification that allows it to bind covalently to circulating albumin, extending its active half-life from minutes to…
MGF and PEG-MGF: Mechano Growth Factor, Satellite Cell Activation and Muscle Repair Research (UK 2026)Mechano Growth Factor (MGF) is a splice variant of IGF-1 produced locally in skeletal muscle in response to mechanical loading and damage — the molecular signal that initiates satellite cell activation and muscle repair after exercise-induced microtrauma. PEG-MGF is a…
IGF-1 LR3 and Muscle Protein Synthesis: mTOR Signalling, Satellite Cells and Anabolic Biology (UK 2026)IGF-1 LR3 (Long Arg3 IGF-1) is a modified form of insulin-like growth factor 1 engineered for extended half-life and reduced IGF binding protein (IGFBP) affinity. It retains full IGF-1 receptor (IGF-1R) binding and activation capacity while remaining biologically active in…
Sermorelin vs HGH: Comparing Growth Hormone Research Approaches (UK 2026)For researchers studying the growth hormone axis, a fundamental question is whether to use recombinant human growth hormone (rhGH) directly or to stimulate endogenous GH release using a GH secretagogue such as sermorelin. The distinction matters enormously for study design — each approach produces a…
BPC-157 and Tendon Repair Research: Mechanisms, Models and Connective Tissue Biology (UK 2026)Of all the tissue types studied in BPC-157 research, tendons and ligaments represent the most consistently and specifically documented area of accelerated repair. Multiple independent research groups have confirmed that BPC-157 accelerates tendon healing across different injury models, different anatomical locations, and…
Kisspeptin-10 and Fertility Research: LH Pulse Biology, HPG Axis and Reproductive Science (UK 2026)Kisspeptin-10 is the biologically active decapeptide fragment derived from kisspeptin-54 — the full-length protein product of the KISS1 gene. Its discovery in 2003 as the endogenous activator of GnRH-secreting neurons in the hypothalamus transformed reproductive neuroendocrinology, revealing the molecular master switch…
Hexarelin and Cardiac Research: GHS-R1a Cardioprotection and Heart Failure Biology (UK 2026)Hexarelin is a synthetic hexapeptide GH secretagogue — His-D-2-Me-Trp-Ala-Trp-D-Phe-Lys-NH₂ — that activates GHS-R1a (the ghrelin receptor) with high potency. While sharing the core GH secretagogue mechanism with GHRP-6 and Ipamorelin, Hexarelin has attracted significant research attention for a distinct reason: of all the…
GHRP-6 and Appetite Research: Ghrelin Mimicry, GH Secretion and Metabolic Biology (UK 2026)GHRP-6 (Growth Hormone Releasing Peptide-6) is a synthetic hexapeptide GH secretagogue that acts as a functional ghrelin mimetic — it activates the ghrelin receptor (GHS-R1a) to stimulate GH release from the anterior pituitary. Unlike GHRH analogues (sermorelin, CJC-1295), which amplify the pituitary's…
